Design of peptide and polypeptide vaccines

Design of peptide and polypeptide vaccines

Advances have been made in the development of vaccines based on synthetic peptides and polypeptides representing tumor-associated antigens and protective epitopes of viruses and parasites. Advances within the past year include the design of vaccines based on artificial proteins, for example multiant...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current opinion in biotechnology 1997-08, Vol.8 (4), p.442-448
Hauptverfasser: Ben-Yedidia, Tamar, Arnon, Ruth
Format: Artikel
Sprache:eng
Schlagworte:
AIDS Vaccines - chemical synthesis
AIDS/HIV
Animals
Cancer Vaccines - chemical synthesis
Drug Carriers
Drug Design
Humans
Influenza Vaccines - chemical synthesis
Malaria Vaccines - chemical synthesis
Peptides - chemical synthesis
Protein Engineering
Schistosomiasis - prevention & control
Vaccines, Synthetic
Viruses
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 448
container_issue 4
container_start_page 442
container_title Current opinion in biotechnology
container_volume 8
creator Ben-Yedidia, Tamar
Arnon, Ruth
description Advances have been made in the development of vaccines based on synthetic peptides and polypeptides representing tumor-associated antigens and protective epitopes of viruses and parasites. Advances within the past year include the design of vaccines based on artificial proteins, for example multiantigen peptides, branched polypeptides, fusion and recombinant peptides, as well as single T cell epitopes and tumor antigen peptides. Although peptide vaccines are not in use as yet, their potential is being explored.
doi_str_mv 10.1016/S0958-1669(97)80066-3
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79225180</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0958166997800663</els_id><sourcerecordid>16256074</sourcerecordid><originalsourceid>FETCH-LOGICAL-c428t-8a079fe8664b88d49bbf829873b817399589818a2433cd793c51a7af7cefbbb03</originalsourceid><addsrcrecordid>eNqFkEtLw0AUhQdRaq3-hEJWokJ0Hsk8ViL1CQUX6nqYmdyRkTSJmaTQf2_6sNuuLpdzzj2XD6EpwbcEE373gVUuU8K5ulLiWmLMecqO0JhIoVKcUXWMxnvLKTqL8QdjnDOBR2ikKM8FZWN08wgxfFdJ7ZMGmi4UkJiqSJq6XP3vS-NcqCCeoxNvyggXuzlBX89Pn7PXdP7-8jZ7mKcuo7JLpcFCeZCcZ1bKIlPWekmVFMxKIpgaXlKSSEMzxlwhFHM5McJ44cBbazGboMvt3aatf3uInV6E6KAsTQV1H7VQlOZEHjYSTnOORTYY863RtXWMLXjdtGFh2pUmWK9h6g1MvSalldAbmJoNuemuoLcLKPapHb1Bv9_qMOBYBmh1dAEqB0VowXW6qMOBhj8ahIJE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16256074</pqid></control><display><type>article</type><title>Design of peptide and polypeptide vaccines</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Ben-Yedidia, Tamar ; Arnon, Ruth</creator><creatorcontrib>Ben-Yedidia, Tamar ; Arnon, Ruth</creatorcontrib><description>Advances have been made in the development of vaccines based on synthetic peptides and polypeptides representing tumor-associated antigens and protective epitopes of viruses and parasites. Advances within the past year include the design of vaccines based on artificial proteins, for example multiantigen peptides, branched polypeptides, fusion and recombinant peptides, as well as single T cell epitopes and tumor antigen peptides. Although peptide vaccines are not in use as yet, their potential is being explored.</description><identifier>ISSN: 0958-1669</identifier><identifier>EISSN: 1879-0429</identifier><identifier>DOI: 10.1016/S0958-1669(97)80066-3</identifier><identifier>PMID: 9265723</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>AIDS Vaccines - chemical synthesis ; AIDS/HIV ; Animals ; Cancer Vaccines - chemical synthesis ; Drug Carriers ; Drug Design ; Humans ; Influenza Vaccines - chemical synthesis ; Malaria Vaccines - chemical synthesis ; Peptides - chemical synthesis ; Protein Engineering ; Schistosomiasis - prevention &amp; control ; Vaccines, Synthetic ; Viruses</subject><ispartof>Current opinion in biotechnology, 1997-08, Vol.8 (4), p.442-448</ispartof><rights>1997</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c428t-8a079fe8664b88d49bbf829873b817399589818a2433cd793c51a7af7cefbbb03</citedby><cites>FETCH-LOGICAL-c428t-8a079fe8664b88d49bbf829873b817399589818a2433cd793c51a7af7cefbbb03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0958166997800663$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9265723$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ben-Yedidia, Tamar</creatorcontrib><creatorcontrib>Arnon, Ruth</creatorcontrib><title>Design of peptide and polypeptide vaccines</title><title>Current opinion in biotechnology</title><addtitle>Curr Opin Biotechnol</addtitle><description>Advances have been made in the development of vaccines based on synthetic peptides and polypeptides representing tumor-associated antigens and protective epitopes of viruses and parasites. Advances within the past year include the design of vaccines based on artificial proteins, for example multiantigen peptides, branched polypeptides, fusion and recombinant peptides, as well as single T cell epitopes and tumor antigen peptides. Although peptide vaccines are not in use as yet, their potential is being explored.</description><subject>AIDS Vaccines - chemical synthesis</subject><subject>AIDS/HIV</subject><subject>Animals</subject><subject>Cancer Vaccines - chemical synthesis</subject><subject>Drug Carriers</subject><subject>Drug Design</subject><subject>Humans</subject><subject>Influenza Vaccines - chemical synthesis</subject><subject>Malaria Vaccines - chemical synthesis</subject><subject>Peptides - chemical synthesis</subject><subject>Protein Engineering</subject><subject>Schistosomiasis - prevention &amp; control</subject><subject>Vaccines, Synthetic</subject><subject>Viruses</subject><issn>0958-1669</issn><issn>1879-0429</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEtLw0AUhQdRaq3-hEJWokJ0Hsk8ViL1CQUX6nqYmdyRkTSJmaTQf2_6sNuuLpdzzj2XD6EpwbcEE373gVUuU8K5ulLiWmLMecqO0JhIoVKcUXWMxnvLKTqL8QdjnDOBR2ikKM8FZWN08wgxfFdJ7ZMGmi4UkJiqSJq6XP3vS-NcqCCeoxNvyggXuzlBX89Pn7PXdP7-8jZ7mKcuo7JLpcFCeZCcZ1bKIlPWekmVFMxKIpgaXlKSSEMzxlwhFHM5McJ44cBbazGboMvt3aatf3uInV6E6KAsTQV1H7VQlOZEHjYSTnOORTYY863RtXWMLXjdtGFh2pUmWK9h6g1MvSalldAbmJoNuemuoLcLKPapHb1Bv9_qMOBYBmh1dAEqB0VowXW6qMOBhj8ahIJE</recordid><startdate>19970801</startdate><enddate>19970801</enddate><creator>Ben-Yedidia, Tamar</creator><creator>Arnon, Ruth</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19970801</creationdate><title>Design of peptide and polypeptide vaccines</title><author>Ben-Yedidia, Tamar ; Arnon, Ruth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c428t-8a079fe8664b88d49bbf829873b817399589818a2433cd793c51a7af7cefbbb03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>AIDS Vaccines - chemical synthesis</topic><topic>AIDS/HIV</topic><topic>Animals</topic><topic>Cancer Vaccines - chemical synthesis</topic><topic>Drug Carriers</topic><topic>Drug Design</topic><topic>Humans</topic><topic>Influenza Vaccines - chemical synthesis</topic><topic>Malaria Vaccines - chemical synthesis</topic><topic>Peptides - chemical synthesis</topic><topic>Protein Engineering</topic><topic>Schistosomiasis - prevention &amp; control</topic><topic>Vaccines, Synthetic</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ben-Yedidia, Tamar</creatorcontrib><creatorcontrib>Arnon, Ruth</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Current opinion in biotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ben-Yedidia, Tamar</au><au>Arnon, Ruth</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Design of peptide and polypeptide vaccines</atitle><jtitle>Current opinion in biotechnology</jtitle><addtitle>Curr Opin Biotechnol</addtitle><date>1997-08-01</date><risdate>1997</risdate><volume>8</volume><issue>4</issue><spage>442</spage><epage>448</epage><pages>442-448</pages><issn>0958-1669</issn><eissn>1879-0429</eissn><abstract>Advances have been made in the development of vaccines based on synthetic peptides and polypeptides representing tumor-associated antigens and protective epitopes of viruses and parasites. Advances within the past year include the design of vaccines based on artificial proteins, for example multiantigen peptides, branched polypeptides, fusion and recombinant peptides, as well as single T cell epitopes and tumor antigen peptides. Although peptide vaccines are not in use as yet, their potential is being explored.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>9265723</pmid><doi>10.1016/S0958-1669(97)80066-3</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0958-1669
ispartof Current opinion in biotechnology, 1997-08, Vol.8 (4), p.442-448
issn 0958-1669
1879-0429
language eng
recordid cdi_proquest_miscellaneous_79225180
source MEDLINE; Elsevier ScienceDirect Journals
subjects AIDS Vaccines - chemical synthesis
AIDS/HIV
Animals
Cancer Vaccines - chemical synthesis
Drug Carriers
Drug Design
Humans
Influenza Vaccines - chemical synthesis
Malaria Vaccines - chemical synthesis
Peptides - chemical synthesis
Protein Engineering
Schistosomiasis - prevention & control
Vaccines, Synthetic
Viruses
title Design of peptide and polypeptide vaccines
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T08%3A07%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Design%20of%20peptide%20and%20polypeptide%20vaccines&rft.jtitle=Current%20opinion%20in%20biotechnology&rft.au=Ben-Yedidia,%20Tamar&rft.date=1997-08-01&rft.volume=8&rft.issue=4&rft.spage=442&rft.epage=448&rft.pages=442-448&rft.issn=0958-1669&rft.eissn=1879-0429&rft_id=info:doi/10.1016/S0958-1669(97)80066-3&rft_dat=%3Cproquest_cross%3E16256074%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16256074&rft_id=info:pmid/9265723&rft_els_id=S0958166997800663&rfr_iscdi=true